{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Alzheimer\u2019s disease", "amyloid beta", "anti-inflammatory", "antioxidant", "herbal medicine", "natural products", "oxidative stress", "tau protein"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35314596", "DateRevised": {"Year": "2022", "Month": "03", "Day": "25"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "02", "Day": "26"}], "Language": ["eng"], "ELocationID": ["24", "10.3390/geriatrics7020024"], "Journal": {"ISSN": "2308-3417", "JournalIssue": {"Volume": "7", "Issue": "2", "PubDate": {"Year": "2022", "Month": "Feb", "Day": "26"}}, "Title": "Geriatrics (Basel, Switzerland)", "ISOAbbreviation": "Geriatrics (Basel)"}, "ArticleTitle": "The Multifaceted Role of Neuroprotective Plants in Alzheimer's Disease Treatment.", "Abstract": {"AbstractText": ["Alzheimer's disease (AD) is an age-related, progressive neurodegenerative disorder characterized by impaired cognition, memory loss, and altered personality. Many of the available pharmaceutical treatments do not alter the onset of disease progression. Recently, alternatives to developed drug candidates have been explored including medicinal plants and herbal treatments for the treatment of AD. This article examines the role of herbal plant extracts and the neuroprotective effects as alternative modes of intervention for AD progression. These extracts contain key metabolites that culminate alterations in AD progression. The traditional plant extracts explored in this article induce a variety of beneficial properties, including antioxidants, anti-inflammatory, and enhanced cognition, while also inducing activity on AD drug targets such as A\u03b2 degradation. While these neuroprotective aspects for AD are relatively recent, there is great potential in the drug discovery aspect of these plant extracts for future use in AD treatment."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Sciences, Taneja College of Pharmacy, University of South Florida, Tampa, FL 33620, USA."}], "LastName": "Zieneldien", "ForeName": "Tarek", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Sciences, Taneja College of Pharmacy, University of South Florida, Tampa, FL 33620, USA."}], "LastName": "Kim", "ForeName": "Janice", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Sciences, Taneja College of Pharmacy, University of South Florida, Tampa, FL 33620, USA."}], "LastName": "Cao", "ForeName": "Chuanhai", "Initials": "C"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Geriatrics (Basel)", "NlmUniqueID": "101704019", "ISSNLinking": "2308-3417"}, "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Alzheimer\u2019s Association 2021 Alzheimer\u2019s disease facts and figures. Alzheimer\u2019s Dement. 2021;17:327\u2013406. doi: 10.1002/alz.12328.", "ArticleIdList": ["10.1002/alz.12328", "33756057"]}, {"Citation": "Corey-Bloom J. The ABC of Alzheimer\u2019s disease: Cognitive changes and their management in Alzheimer\u2019s disease and related dementias. Int. Psychogeriatr. 2002;14((Suppl. 1)):51\u201375. doi: 10.1017/S1041610203008664.", "ArticleIdList": ["10.1017/S1041610203008664", "12636180"]}, {"Citation": "Bekris L.M., Yu C.E., Bird T.D., Tsuang D.W. Genetics of Alzheimer disease. J. Geriatr. Psychiatry Neurol. 2010;23:213\u2013227. doi: 10.1177/0891988710383571.", "ArticleIdList": ["10.1177/0891988710383571", "PMC3044597", "21045163"]}, {"Citation": "Huang Y. Roles of apolipoprotein E4 (ApoE4) in the pathogenesis of Alzheimer\u2019s disease: Lessons from ApoE mouse models. Biochem. Soc. Trans. 2011;39:924\u2013932. doi: 10.1042/BST0390924.", "ArticleIdList": ["10.1042/BST0390924", "21787325"]}, {"Citation": "Guerreiro R., Bras J. The age factor in Alzheimer\u2019s disease. Genome Med. 2015;7:106. doi: 10.1186/s13073-015-0232-5.", "ArticleIdList": ["10.1186/s13073-015-0232-5", "PMC4617238", "26482651"]}, {"Citation": "Hebert L.E., Weuve J., Scherr P.A., Evans D.A. Alzheimer disease in the United States (2010\u20132050) estimated using the 2010 census. Neurology. 2013;80:1778\u20131783. doi: 10.1212/WNL.0b013e31828726f5.", "ArticleIdList": ["10.1212/WNL.0b013e31828726f5", "PMC3719424", "23390181"]}, {"Citation": "Farrer L.A., Cupples L.A., Haines J.L., Hyman B., Kukull W.A., Mayeux R., Myers R.H., Pericak-Vance M.A., Risch N., van Duijn C.M. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA. 1997;278:1349\u20131356. doi: 10.1001/jama.1997.03550160069041.", "ArticleIdList": ["10.1001/jama.1997.03550160069041", "9343467"]}, {"Citation": "Reitz C. Toward precision medicine in Alzheimer\u2019s disease. Ann. Transl. Med. 2016;4:107. doi: 10.21037/atm.2016.03.05.", "ArticleIdList": ["10.21037/atm.2016.03.05", "PMC4828743", "27127760"]}, {"Citation": "Oxford A.E., Stewart E.S., Rohn T.T. Clinical Trials in Alzheimer\u2019s Disease: A Hurdle in the Path of Remedy. Int. J. Alzheimer\u2019s Dis. 2020;2020:5380346. doi: 10.1155/2020/5380346.", "ArticleIdList": ["10.1155/2020/5380346", "PMC7152954", "32308993"]}, {"Citation": "Tan C.C., Yu J.T., Wang H.F., Tan M.S., Meng X.F., Wang C., Jiang T., Zhu X.C., Tan L. Efficacy and safety of donepezil, galantamine, rivastigmine, and memantine for the treatment of Alzheimer\u2019s disease: A systematic review and meta-analysis. J. Alzheimer\u2019s Dis. 2014;41:615\u2013631. doi: 10.3233/JAD-132690.", "ArticleIdList": ["10.3233/JAD-132690", "24662102"]}, {"Citation": "Dunn B., Stein P., Temple R., Cavazzoni P. An Appropriate Use of Accelerated Approval\u2014Aducanumab for Alzheimer\u2019s Disease. N. Engl. J. Med. 2021;385:856\u2013857. doi: 10.1056/NEJMc2111960.", "ArticleIdList": ["10.1056/NEJMc2111960", "34320283"]}, {"Citation": "Vickers J.C., Dickson T.C., Adlard P.A., Saunders H.L., King C.E., McCormack G. The cause of neuronal degeneration in Alzheimer\u2019s disease. Prog. Neurobiol. 2000;60:139\u2013165. doi: 10.1016/S0301-0082(99)00023-4.", "ArticleIdList": ["10.1016/S0301-0082(99)00023-4", "10639052"]}, {"Citation": "Whitwell J.L. Progression of atrophy in Alzheimer\u2019s disease and related disorders. Neurotox. Res. 2010;18:339\u2013346. doi: 10.1007/s12640-010-9175-1.", "ArticleIdList": ["10.1007/s12640-010-9175-1", "20352396"]}, {"Citation": "De-Paula V.J., Radanovic M., Diniz B.S., Forlenza O.V. Alzheimer\u2019s disease. Subcell. Biochem. 2012;65:329\u2013352. doi: 10.1007/978-94-007-5416-4_14.", "ArticleIdList": ["10.1007/978-94-007-5416-4_14", "23225010"]}, {"Citation": "N\u00e4slund J., Haroutunian V., Mohs R., Davis K.L., Davies P., Greengard P., Buxbaum J.D. Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline. JAMA. 2000;283:1571\u20131577. doi: 10.1001/jama.283.12.1571.", "ArticleIdList": ["10.1001/jama.283.12.1571", "10735393"]}, {"Citation": "Bent S. Herbal medicine in the United States: Review of efficacy, safety, and regulation: Grand rounds at University of California, San Francisco Medical Center. J. Gen. Intern. Med. 2008;23:854\u2013859. doi: 10.1007/s11606-008-0632-y.", "ArticleIdList": ["10.1007/s11606-008-0632-y", "PMC2517879", "18415652"]}, {"Citation": "Eckert G.P. Traditional used Plants against Cognitive Decline and Alzheimer Disease. Front. Pharmacol. 2010;1:138. doi: 10.3389/fphar.2010.00138.", "ArticleIdList": ["10.3389/fphar.2010.00138", "PMC3153012", "21833177"]}, {"Citation": "Ricciarelli R., Fedele E. The Amyloid Cascade Hypothesis in Alzheimer\u2019s Disease: It\u2019s Time to Change Our Mind. Curr. Neuropharmacol. 2017;15:926\u2013935. doi: 10.2174/1570159X15666170116143743.", "ArticleIdList": ["10.2174/1570159X15666170116143743", "PMC5652035", "28093977"]}, {"Citation": "Maccioni R.B., Far\u00edas G., Morales I., Navarrete L. The revitalized tau hypothesis on Alzheimer\u2019s disease. Arch. Med. Res. 2010;41:226\u2013231. doi: 10.1016/j.arcmed.2010.03.007.", "ArticleIdList": ["10.1016/j.arcmed.2010.03.007", "20682182"]}, {"Citation": "Liu P.P., Xie Y., Meng X.Y., Kang J.S. History and progress of hypotheses and clinical trials for Alzheimer\u2019s disease. Signal Transduct. Target. Ther. 2019;4:29. doi: 10.1038/s41392-019-0063-8.", "ArticleIdList": ["10.1038/s41392-019-0063-8", "PMC6799833", "31637009"]}, {"Citation": "Hardy J.A., Higgins G.A. Alzheimer\u2019s disease: The amyloid cascade hypothesis. Science. 1992;256:184\u2013185. doi: 10.1126/science.1566067.", "ArticleIdList": ["10.1126/science.1566067", "1566067"]}, {"Citation": "Busche M.A., Wegmann S., Dujardin S., Commins C., Schiantarelli J., Klickstein N., Kamath T.V., Carlson G.A., Nelken I., Hyman B.T. Tau impairs neural circuits, dominating amyloid-\u03b2 effects, in Alzheimer models in vivo. Nat. Neurosci. 2019;22:57\u201364. doi: 10.1038/s41593-018-0289-8.", "ArticleIdList": ["10.1038/s41593-018-0289-8", "PMC6560629", "30559471"]}, {"Citation": "Frost B., Jacks R.L., Diamond M.I. Propagation of tau misfolding from the outside to the inside of a cell. J. Biol. Chem. 2009;284:12845\u201312852. doi: 10.1074/jbc.M808759200.", "ArticleIdList": ["10.1074/jbc.M808759200", "PMC2676015", "19282288"]}, {"Citation": "Kinney J.W., Bemiller S.M., Murtishaw A.S., Leisgang A.M., Salazar A.M., Lamb B.T. Inflammation as a central mechanism in Alzheimer\u2019s disease. Alzheimer\u2019s Dement. 2018;4:575\u2013590. doi: 10.1016/j.trci.2018.06.014.", "ArticleIdList": ["10.1016/j.trci.2018.06.014", "PMC6214864", "30406177"]}, {"Citation": "Francis P.T., Palmer A.M., Snape M., Wilcock G.K. The cholinergic hypothesis of Alzheimer\u2019s disease: A review of progress. J. Neurol. Neurosurg. Psychiatry. 1999;66:137\u2013147. doi: 10.1136/jnnp.66.2.137.", "ArticleIdList": ["10.1136/jnnp.66.2.137", "PMC1736202", "10071091"]}, {"Citation": "Birks J. Cholinesterase inhibitors for Alzheimer\u2019s disease. Cochrane Database Syst. Rev. 2006;1:CD005593. doi: 10.1002/14651858.CD005593.", "ArticleIdList": ["10.1002/14651858.CD005593", "PMC9006343", "16437532"]}, {"Citation": "Huang W.J., Zhang X., Chen W.W. Role of oxidative stress in Alzheimer\u2019s disease. Biomed. Rep. 2016;4:519\u2013522. doi: 10.3892/br.2016.630.", "ArticleIdList": ["10.3892/br.2016.630", "PMC4840676", "27123241"]}, {"Citation": "Markesbery W.R. Oxidative stress hypothesis in Alzheimer\u2019s disease. Free Radic. Biol. Med. 1997;23:134\u2013147. doi: 10.1016/S0891-5849(96)00629-6.", "ArticleIdList": ["10.1016/S0891-5849(96)00629-6", "9165306"]}, {"Citation": "Hardy J., Selkoe D.J. The amyloid hypothesis of Alzheimer\u2019s disease: Progress and problems on the road to therapeutics. Science. 2002;297:353\u2013356. doi: 10.1126/science.1072994.", "ArticleIdList": ["10.1126/science.1072994", "12130773"]}, {"Citation": "Izzo N.J., Staniszewski A., To L., Fa M., Teich A.F., Saeed F., Wostein H., Walko T., Vaswani A., Wardius M., et al. Alzheimer\u2019s therapeutics targeting amyloid beta 1-42 oligomers I: Abeta 42 oligomer binding to specific neuronal receptors is displaced by drug candidates that improve cognitive deficits. PLoS ONE. 2014;9:e111898. doi: 10.1371/journal.pone.0111898.", "ArticleIdList": ["10.1371/journal.pone.0111898", "PMC4229098", "25390368"]}, {"Citation": "Conway K.A., Baxter E.W., Felsenstein K.M., Reitz A.B. Emerging beta-amyloid therapies for the treatment of Alzheimer\u2019s disease. Curr. Pharm. Des. 2003;9:427\u2013447. doi: 10.2174/1381612033391649.", "ArticleIdList": ["10.2174/1381612033391649", "12570807"]}, {"Citation": "Tickler A.K., Wade J.D., Separovic F. The role of Abeta peptides in Alzheimer\u2019s disease. Protein Pept. Lett. 2005;12:513\u2013519. doi: 10.2174/0929866054395905.", "ArticleIdList": ["10.2174/0929866054395905", "16101387"]}, {"Citation": "Uddin M.S., Al Mamun A., Kabir M.T., Ashraf G.M., Bin-Jumah M.N., Abdel-Daim M.M. Multi-Target Drug Candidates for Multifactorial Alzheimer\u2019s Disease: AChE and NMDAR as Molecular Targets. Mol. Neurobiol. 2021;58:281\u2013303. doi: 10.1007/s12035-020-02116-9.", "ArticleIdList": ["10.1007/s12035-020-02116-9", "32935230"]}, {"Citation": "Gonz\u00e1lez J.F., Alc\u00e1ntara A.R., Doadrio A.L., S\u00e1nchez-Montero J.M. Developments with multi-target drugs for Alzheimer\u2019s disease: An overview of the current discovery approaches. Expert Opin. Drug Discov. 2019;14:879\u2013891. doi: 10.1080/17460441.2019.1623201.", "ArticleIdList": ["10.1080/17460441.2019.1623201", "31165654"]}, {"Citation": "Longo F.M., Massa S.M. Neuroprotective strategies in Alzheimer\u2019s disease. NeuroRx. 2004;1:117\u2013127. doi: 10.1602/neurorx.1.1.117.", "ArticleIdList": ["10.1602/neurorx.1.1.117", "PMC534917", "15717012"]}, {"Citation": "Niikura T., Tajima H., Kita Y. Neuronal cell death in Alzheimer\u2019s disease and a neuroprotective factor, humanin. Curr. Neuropharmacol. 2006;4:139\u2013147. doi: 10.2174/157015906776359577.", "ArticleIdList": ["10.2174/157015906776359577", "PMC2430668", "18615127"]}, {"Citation": "Heneka M.T., Carson M.J., El Khoury J., Landreth G.E., Brosseron F., Feinstein D.L., Jacobs A.H., Wyss-Coray T., Vitorica J., Ransohoff R.M., et al. Neuroinflammation in Alzheimer\u2019s disease. Lancet Neurol. 2015;14:388\u2013405. doi: 10.1016/S1474-4422(15)70016-5.", "ArticleIdList": ["10.1016/S1474-4422(15)70016-5", "PMC5909703", "25792098"]}, {"Citation": "Ferreira-Vieira T.H., Guimaraes I.M., Silva F.R., Ribeiro F.M. Alzheimer\u2019s disease: Targeting the Cholinergic System. Curr. Neuropharmacol. 2016;14:101\u2013115. doi: 10.2174/1570159X13666150716165726.", "ArticleIdList": ["10.2174/1570159X13666150716165726", "PMC4787279", "26813123"]}, {"Citation": "Ding Y., Zhao J., Zhang X., Wang S., Viola K.L., Chow F.E., Zhang Y., Lippa C., Klein W.L., Gong Y. Amyloid Beta Oligomers Target to Extracellular and Intracellular Neuronal Synaptic Proteins in Alzheimer\u2019s Disease. Front. Neurol. 2019;10:1140. doi: 10.3389/fneur.2019.01140.", "ArticleIdList": ["10.3389/fneur.2019.01140", "PMC6838211", "31736856"]}, {"Citation": "Quiroz-Baez R., Ferrera P., Rosendo-Guti\u00e9rrez R., Mor\u00e1n J., Berm\u00fadez-Rattoni F., Arias C. Caspase-12 activation is involved in amyloid-\u03b2 protein-induced synaptic toxicity. J. Alzheimer\u2019s Dis. 2011;26:467\u2013476. doi: 10.3233/JAD-2011-110326.", "ArticleIdList": ["10.3233/JAD-2011-110326", "21694457"]}, {"Citation": "Iqbal K., Liu F., Gong C.X., Grundke-Iqbal I. Tau in Alzheimer disease and related tauopathies. Curr. Alzheimer Res. 2010;7:656\u2013664. doi: 10.2174/156720510793611592.", "ArticleIdList": ["10.2174/156720510793611592", "PMC3090074", "20678074"]}, {"Citation": "Pradeep S., Jain A.S., Dharmashekara C., Prasad S.K., Kollur S.P., Syed A., Shivamallu C. Alzheimer\u2019s Disease and Herbal Combination Therapy: A Comprehensive Review. J. Alzheimer\u2019s Dis. Rep. 2020;4:417\u2013429. doi: 10.3233/ADR-200228.", "ArticleIdList": ["10.3233/ADR-200228", "PMC7683102", "33283163"]}, {"Citation": "Olila D., Opuda-Asibo J. Antibacterial and antifungal activities of extracts of Zanthoxylum chalybeum and Warburgia ugandensis, Ugandan medicinal plants. Afr. Health Sci. 2001;1:66\u201372.", "ArticleIdList": ["PMC2141554", "12789119"]}, {"Citation": "Droy-Lefaix M.T. Effect of the antioxidant action of Ginkgo biloba extract (EGb 761) on aging and oxidative stress. Age. 1997;20:141\u2013149. doi: 10.1007/s11357-997-0013-1.", "ArticleIdList": ["10.1007/s11357-997-0013-1", "PMC3455891", "23604306"]}, {"Citation": "Shal B., Ding W., Ali H., Kim Y.S., Khan S. Anti-neuroinflammatory Potential of Natural Products in Attenuation of Alzheimer\u2019s Disease. Front. Pharmacol. 2018;9:548. doi: 10.3389/fphar.2018.00548.", "ArticleIdList": ["10.3389/fphar.2018.00548", "PMC5986949", "29896105"]}, {"Citation": "Noori T., Dehpour A.R., Sureda A., Sobarzo-Sanchez E., Shirooie S. Role of natural products for the treatment of Alzheimer\u2019s disease. Eur. J. Pharmacol. 2021;898:173974. doi: 10.1016/j.ejphar.2021.173974.", "ArticleIdList": ["10.1016/j.ejphar.2021.173974", "33652057"]}, {"Citation": "Koynova R., Tenchov B. Natural Product Formulations for the Prevention and Treatment of Alzheimer\u2019s disease: A Patent Review. Recent Pat. Drug Deliv. Formul. 2018;12:23\u201339. doi: 10.2174/1872211312666171207152326.", "ArticleIdList": ["10.2174/1872211312666171207152326", "29219064"]}, {"Citation": "Patwardhan B., Warude D., Pushpangadan P., Bhatt N. Ayurveda and traditional Chinese medicine: A comparative overview. Evid.-Based Complement. Altern. Med. 2005;2:465\u2013473. doi: 10.1093/ecam/neh140.", "ArticleIdList": ["10.1093/ecam/neh140", "PMC1297513", "16322803"]}, {"Citation": "Koithan M., Farrell C. Indigenous Native American Healing Traditions. J. Nurse Pract. 2010;6:477\u2013478. doi: 10.1016/j.nurpra.2010.03.016.", "ArticleIdList": ["10.1016/j.nurpra.2010.03.016", "PMC2913884", "20689671"]}, {"Citation": "Singh M., Ramassamy C. Screening of neuroprotective activity of Indian medicinal plant. J. Nutr Sci. 2017;6:e54. doi: 10.1017/jns.2017.48.", "ArticleIdList": ["10.1017/jns.2017.48", "PMC5672322", "29152258"]}, {"Citation": "Jayaprakasam B., Padmanabhan K., Nair M.G. Withanamides in Withania somnifera fruit protect PC-12 cells from beta-amyloid responsible for Alzheimer\u2019s disease. Phytother. Res. 2010;24:859\u2013863. doi: 10.1002/ptr.3033.", "ArticleIdList": ["10.1002/ptr.3033", "19957250"]}, {"Citation": "Pratte M.A., Nanavati K.B., Young V., Morley C.P. An alternative treatment for anxiety: A systematic review of human trial results reported for the Ayurvedic herb ashwagandha (Withania somnifera) J. Altern. Complement. Med. 2014;20:901\u2013908. doi: 10.1089/acm.2014.0177.", "ArticleIdList": ["10.1089/acm.2014.0177", "PMC4270108", "25405876"]}, {"Citation": "Pingali U., Pilli R., Fatima N. Effect of standardized aqueous extract of Withania somnifera on tests of cognitive and psychomotor performance in healthy human participants. Pharmacogn. Res. 2014;6:12\u201318. doi: 10.4103/0974-8490.122912.", "ArticleIdList": ["10.4103/0974-8490.122912", "PMC3897003", "24497737"]}, {"Citation": "Chengappa K.N., Bowie C.R., Schlicht P.J., Fleet D., Brar J.S., Jindal R. Randomized placebo-controlled adjunctive study of an extract of withania somnifera for cognitive dysfunction in bipolar disorder. J. Clin. Psychiatry. 2013;74:1076\u20131083. doi: 10.4088/JCP.13m08413.", "ArticleIdList": ["10.4088/JCP.13m08413", "24330893"]}, {"Citation": "Russo A., Borrelli F. Bacopa monniera, a reputed nootropic plant: An overview. Phytomedicine. 2005;12:305\u2013317. doi: 10.1016/j.phymed.2003.12.008.", "ArticleIdList": ["10.1016/j.phymed.2003.12.008", "15898709"]}, {"Citation": "Uabundit N., Wattanathorn J., Mucimapura S., Ingkaninan K. Cognitive enhancement and neuroprotective effects of Bacopa monnieri in Alzheimer\u2019s disease model. J. Ethnopharmacol. 2010;127:26\u201331. doi: 10.1016/j.jep.2009.09.056.", "ArticleIdList": ["10.1016/j.jep.2009.09.056", "19808086"]}, {"Citation": "Limpeanchob N., Jaipan S., Rattanakaruna S., Phrompittayarat W., Ingkaninan K. Neuroprotective effect of Bacopa monnieri on beta-amyloid-induced cell death in primary cortical culture. J. Ethnopharmacol. 2008;120:112\u2013117. doi: 10.1016/j.jep.2008.07.039.", "ArticleIdList": ["10.1016/j.jep.2008.07.039", "18755259"]}, {"Citation": "Raghav S., Singh H., Dalal P.K., Srivastava J.S., Asthana O.P. Randomized controlled trial of standardized Bacopa monniera extract in age-associated memory impairment. Indian J. Psychiatry. 2006;48:238\u2013242. doi: 10.4103/0019-5545.31555.", "ArticleIdList": ["10.4103/0019-5545.31555", "PMC2915594", "20703343"]}, {"Citation": "Osman N.M., Amer A.S., Abdelwahab S. Effects of Ginko biloba leaf extract on the neurogenesis of the hippocampal dentate gyrus in the elderly mice. Anat. Sci. Int. 2016;91:280\u2013289. doi: 10.1007/s12565-015-0297-7.", "ArticleIdList": ["10.1007/s12565-015-0297-7", "26297531"]}, {"Citation": "Zhao J., Li K., Wang Y., Li D., Wang Q., Xie S., Wang J., Zuo Z. Enhanced anti-amnestic effect of donepezil by Ginkgo biloba extract (EGb 761) via further improvement in pro-cholinergic and antioxidative activities. J. Ethnopharmacol. 2021;269:113711. doi: 10.1016/j.jep.2020.113711.", "ArticleIdList": ["10.1016/j.jep.2020.113711", "33352242"]}, {"Citation": "Liu H., Ye M., Guo H. An Updated Review of Randomized Clinical Trials Testing the Improvement of Cognitive Function of. Front. Pharmacol. 2019;10:1688. doi: 10.3389/fphar.2019.01688.", "ArticleIdList": ["10.3389/fphar.2019.01688", "PMC7047126", "32153388"]}, {"Citation": "Mahadevan S., Park Y. Multifaceted therapeutic benefits of Ginkgo biloba L.: Chemistry, efficacy, safety, and uses. J. Food Sci. 2008;73:R14\u2013R19. doi: 10.1111/j.1750-3841.2007.00597.x.", "ArticleIdList": ["10.1111/j.1750-3841.2007.00597.x", "18211362"]}, {"Citation": "Soumyanath A., Zhong Y.P., Henson E., Wadsworth T., Bishop J., Gold B.G., Quinn J.F. Centella asiatica Extract Improves Behavioral Deficits in a Mouse Model of Alzheimer\u2019s Disease: Investigation of a Possible Mechanism of Action. Int. J. Alzheimer\u2019s Dis. 2012;2012:381974. doi: 10.1155/2012/381974.", "ArticleIdList": ["10.1155/2012/381974", "PMC3296229", "22506133"]}, {"Citation": "Veerendra Kumar M.H., Gupta Y.K. Effect of Centella asiatica on cognition and oxidative stress in an intracerebroventricular streptozotocin model of Alzheimer\u2019s disease in rats. Clin. Exp. Pharmacol. Physiol. 2003;30:336\u2013342. doi: 10.1046/j.1440-1681.2003.03842.x.", "ArticleIdList": ["10.1046/j.1440-1681.2003.03842.x", "12859423"]}, {"Citation": "Dhanasekaran M., Holcomb L.A., Hitt A.R., Tharakan B., Porter J.W., Young K.A., Manyam B.V. Centella asiatica extract selectively decreases amyloid beta levels in hippocampus of Alzheimer\u2019s disease animal model. Phytother. Res. 2009;23:14\u201319. doi: 10.1002/ptr.2405.", "ArticleIdList": ["10.1002/ptr.2405", "19048607"]}, {"Citation": "Shinomol G.K., Bharath M.M. Exploring the Role of \u201cBrahmi\u201d (Bacopa monnieri and Centella asiatica) in Brain Function and Therapy. Recent Pat. Endocr. Metab. Immune Drug Discov. 2011;5:33\u201349. doi: 10.2174/187221411794351833.", "ArticleIdList": ["10.2174/187221411794351833", "22074576"]}, {"Citation": "Adalier N., Parker H. Vitamin E, Turmeric and Saffron in Treatment of Alzheimer\u2019s Disease. Antioxidants. 2016;5:40. doi: 10.3390/antiox5040040.", "ArticleIdList": ["10.3390/antiox5040040", "PMC5187538", "27792130"]}, {"Citation": "Khazdair M.R., Boskabady M.H., Hosseini M., Rezaee R., Tsatsakis A.M. The effects of Crocus sativus (saffron) and its constituents on nervous system: A review. Avicenna J. Phytomed. 2015;5:376\u2013391.", "ArticleIdList": ["PMC4599112", "26468457"]}, {"Citation": "Akhondzadeh S., Shafiee Sabet M., Harirchian M.H., Togha M., Cheraghmakani H., Razeghi S., Hejazi S.S., Yousefi M.H., Alimardani R., Jamshidi A., et al. A 22-week, multicenter, randomized, double-blind controlled trial of Crocus sativus in the treatment of mild-to-moderate Alzheimer\u2019s disease. Psychopharmacology. 2010;207:637\u2013643. doi: 10.1007/s00213-009-1706-1.", "ArticleIdList": ["10.1007/s00213-009-1706-1", "19838862"]}, {"Citation": "Batarseh Y.S., Bharate S.S., Kumar V., Kumar A., Vishwakarma R.A., Bharate S.B., Kaddoumi A. Crocus sativus Extract Tightens the Blood-Brain Barrier, Reduces Amyloid \u03b2 Load and Related Toxicity in 5XFAD Mice. ACS Chem. Neurosci. 2017;8:1756\u20131766. doi: 10.1021/acschemneuro.7b00101.", "ArticleIdList": ["10.1021/acschemneuro.7b00101", "PMC5559303", "28471166"]}, {"Citation": "Chen M., Du Z.Y., Zheng X., Li D.L., Zhou R.P., Zhang K. Use of curcumin in diagnosis, prevention, and treatment of Alzheimer\u2019s disease. Neural Regen Res. 2018;13:742\u2013752. doi: 10.4103/1673-5374.230303.", "ArticleIdList": ["10.4103/1673-5374.230303", "PMC5950688", "29722330"]}, {"Citation": "Zhang X., Tian Y., Li Z., Tian X., Sun H., Liu H., Moore A., Ran C. Design and synthesis of curcumin analogues for in vivo fluorescence imaging and inhibiting copper-induced cross-linking of amyloid beta species in Alzheimer\u2019s disease. J. Am. Chem. Soc. 2013;135:16397\u201316409. doi: 10.1021/ja405239v.", "ArticleIdList": ["10.1021/ja405239v", "PMC3927838", "24116384"]}, {"Citation": "Zhang X., Yin W.K., Shi X.D., Li Y. Curcumin activates Wnt/\u03b2-catenin signaling pathway through inhibiting the activity of GSK-3\u03b2 in APPswe transfected SY5Y cells. Eur. J. Pharm. Sci. 2011;42:540\u2013546. doi: 10.1016/j.ejps.2011.02.009.", "ArticleIdList": ["10.1016/j.ejps.2011.02.009", "21352912"]}, {"Citation": "Teter B., Morihara T., Lim G.P., Chu T., Jones M.R., Zuo X., Paul R.M., Frautschy S.A., Cole G.M. Curcumin restores innate immune Alzheimer\u2019s disease risk gene expression to ameliorate Alzheimer pathogenesis. Neurobiol. Dis. 2019;127:432\u2013448. doi: 10.1016/j.nbd.2019.02.015.", "ArticleIdList": ["10.1016/j.nbd.2019.02.015", "PMC8092921", "30951849"]}, {"Citation": "Li X.L., Wang D.S., Zhao B.Q., Li Q., Qu H.Y., Zhang T., Zhou J.P., Sun M.J. Effects of Chinese herbal medicine fuzhisan on aged rats. Exp. Gerontol. 2008;43:853\u2013858. doi: 10.1016/j.exger.2008.05.018.", "ArticleIdList": ["10.1016/j.exger.2008.05.018", "18606218"]}, {"Citation": "Bi M., Tong S., Zhang Z., Ma Q., Zhang S., Luo Z., Zhang Y., Li X., Wang D. Changes in cerebral glucose metabolism in patients with mild-to-moderate Alzheimer\u2019s disease: A pilot study with the Chinese herbal medicine fuzhisan. Neurosci. Lett. 2011;501:35\u201340. doi: 10.1016/j.neulet.2011.06.036.", "ArticleIdList": ["10.1016/j.neulet.2011.06.036", "21741446"]}, {"Citation": "Gao R., Wang Y., Pan Q., Huang G., Li N., Mou J., Wang D. Fuzhisan, a chinese herbal medicine, suppresses beta-secretase gene transcription via upregulation of SIRT1 expression in N2a-APP695 cells. Int. J. Clin. Exp. Med. 2015;8:7231\u20137240.", "ArticleIdList": ["PMC4509207", "26221262"]}, {"Citation": "Singh N., Bhalla M., de Jager P., Gilca M. An overview on ashwagandha: A Rasayana (rejuvenator) of Ayurveda. Afr. J. Tradit. Complement. Altern. Med. 2011;8:208\u2013213. doi: 10.4314/ajtcam.v8i5S.9.", "ArticleIdList": ["10.4314/ajtcam.v8i5S.9", "PMC3252722", "22754076"]}, {"Citation": "Zahiruddin S., Basist P., Parveen A., Parveen R., Khan W., Ahmad S. Ashwagandha in brain disorders: A review of recent developments. J. Ethnopharmacol. 2020;257:112876. doi: 10.1016/j.jep.2020.112876.", "ArticleIdList": ["10.1016/j.jep.2020.112876", "32305638"]}, {"Citation": "Dar N.J. Neurodegenerative diseases and Withania somnifera (L.): An update. J. Ethnopharmacol. 2020;256:112769. doi: 10.1016/j.jep.2020.112769.", "ArticleIdList": ["10.1016/j.jep.2020.112769", "32240781"]}, {"Citation": "Rao R.V., Descamps O., John V., Bredesen D.E. Ayurvedic medicinal plants for Alzheimer\u2019s disease: A review. Alzheimer\u2019s Res. Ther. 2012;4:22. doi: 10.1186/alzrt125.", "ArticleIdList": ["10.1186/alzrt125", "PMC3506936", "22747839"]}, {"Citation": "Matsuda H., Murakami T., Kishi A., Yoshikawa M. Structures of withanosides I, II, III, IV, V, VI, and VII, new withanolide glycosides, from the roots of Indian Withania somnifera DUNAL. and inhibitory activity for tachyphylaxis to clonidine in isolated guinea-pig ileum. Bioorg. Med. Chem. 2001;9:1499\u20131507. doi: 10.1016/S0968-0896(01)00024-4.", "ArticleIdList": ["10.1016/S0968-0896(01)00024-4", "11408168"]}, {"Citation": "Mishra L.C., Singh B.B., Dagenais S. Scientific basis for the therapeutic use of Withania somnifera (ashwagandha): A review. Altern. Med. Rev. 2000;5:334\u2013346.", "ArticleIdList": ["10956379"]}, {"Citation": "Sumathi S., Padma P.R., Gathampari S., Vidhya S. Free radical scavenging activity of different parts of withania somnifera. Anc. Sci. Life. 2007;26:30\u201334.", "ArticleIdList": ["PMC3330878", "22557238"]}, {"Citation": "Kumar S., Harris R.J., Seal C.J., Okello E.J. An aqueous extract of Withania somnifera root inhibits amyloid \u03b2 fibril formation in vitro. Phytother. Res. 2012;26:113\u2013117. doi: 10.1002/ptr.3512.", "ArticleIdList": ["10.1002/ptr.3512", "21567509"]}, {"Citation": "Parihar M.S., Hemnani T. Phenolic antioxidants attenuate hippocampal neuronal cell damage against kainic acid induced excitotoxicity. J. Biosci. 2003;28:121\u2013128. doi: 10.1007/BF02970142.", "ArticleIdList": ["10.1007/BF02970142", "12682435"]}, {"Citation": "Kuboyama T., Tohda C., Zhao J., Nakamura N., Hattori M., Komatsu K. Axon- or dendrite-predominant outgrowth induced by constituents from Ashwagandha. Neuroreport. 2002;13:1715\u20131720. doi: 10.1097/00001756-200210070-00005.", "ArticleIdList": ["10.1097/00001756-200210070-00005", "12395110"]}, {"Citation": "Tohda C., Kuboyama T., Komatsu K. Dendrite extension by methanol extract of Ashwagandha (roots of Withania somnifera) in SK-N-SH cells. Neuroreport. 2000;11:1981\u20131985. doi: 10.1097/00001756-200006260-00035.", "ArticleIdList": ["10.1097/00001756-200006260-00035", "10884056"]}, {"Citation": "Kuboyama T., Tohda C., Komatsu K. Neuritic regeneration and synaptic reconstruction induced by withanolide A. Br. J. Pharmacol. 2005;144:961\u2013971. doi: 10.1038/sj.bjp.0706122.", "ArticleIdList": ["10.1038/sj.bjp.0706122", "PMC1576076", "15711595"]}, {"Citation": "Tohda C., Kuboyama T., Komatsu K. Search for natural products related to regeneration of the neuronal network. Neurosignals. 2005;14:34\u201345. doi: 10.1159/000085384.", "ArticleIdList": ["10.1159/000085384", "15956813"]}, {"Citation": "Sehgal N., Gupta A., Valli R.K., Joshi S.D., Mills J.T., Hamel E., Khanna P., Jain S.C., Thakur S.S., Ravindranath V. Withania somnifera reverses Alzheimer\u2019s disease pathology by enhancing low-density lipoprotein receptor-related protein in liver. Proc. Natl. Acad. Sci. USA. 2012;109:3510\u20133515. doi: 10.1073/pnas.1112209109.", "ArticleIdList": ["10.1073/pnas.1112209109", "PMC3295277", "22308347"]}, {"Citation": "Halim M.A., Rosli I.M., Jaafar S.S.M., Ooi H.-M., Long P.-W., Shamsuddin S., Najimudin N., Azzam G. Withania somnifera Showed Neuroprotective Effect and Increase Longevity in Drosophila Alzheimer\u2019s Disease Model. Cold Spring Harbor Laboratory; Cold Spring Harbor, LI, USA: 2020."}, {"Citation": "Ng Q.X., Loke W., Foo N.X., Tan W.J., Chan H.W., Lim D.Y., Yeo W.S. A systematic review of the clinical use of Withania somnifera (Ashwagandha) to ameliorate cognitive dysfunction. Phytother. Res. 2020;34:583\u2013590. doi: 10.1002/ptr.6552.", "ArticleIdList": ["10.1002/ptr.6552", "31742775"]}, {"Citation": "Choudhary D., Bhattacharyya S., Bose S. Efficacy and Safety of Ashwagandha (Withania somnifera (L.) Dunal) Root Extract in Improving Memory and Cognitive Functions. J. Diet. Suppl. 2017;14:599\u2013612. doi: 10.1080/19390211.2017.1284970.", "ArticleIdList": ["10.1080/19390211.2017.1284970", "28471731"]}, {"Citation": "Aguiar S., Borowski T. Neuropharmacological review of the nootropic herb Bacopa monnieri. Rejuvenation Res. 2013;16:313\u2013326. doi: 10.1089/rej.2013.1431.", "ArticleIdList": ["10.1089/rej.2013.1431", "PMC3746283", "23772955"]}, {"Citation": "Mathew J., Balakrishnan S., Antony S., Abraham P.M., Paulose C.S. Decreased GABA receptor in the cerebral cortex of epileptic rats: Effect of Bacopa monnieri and Bacoside-A. J. Biomed. Sci. 2012;19:25. doi: 10.1186/1423-0127-19-25.", "ArticleIdList": ["10.1186/1423-0127-19-25", "PMC3306740", "22364254"]}, {"Citation": "Jadiya P., Khan A., Sammi S.R., Kaur S., Mir S.S., Nazir A. Anti-Parkinsonian effects of Bacopa monnieri: Insights from transgenic and pharmacological Caenorhabditis elegans models of Parkinson\u2019s disease. Biochem. Biophys. Res. Commun. 2011;413:605\u2013610. doi: 10.1016/j.bbrc.2011.09.010.", "ArticleIdList": ["10.1016/j.bbrc.2011.09.010", "21925152"]}, {"Citation": "Soko\u0142owska L., Bylka W. Bacopa Monnieri-activity and applications in medicine. Wiad. Lek. 2015;68:358\u2013362.", "ArticleIdList": ["28501836"]}, {"Citation": "Channa S., Dar A., Anjum S., Yaqoob M., Atta Ur R. Anti-inflammatory activity of Bacopa monniera in rodents. J. Ethnopharmacol. 2006;104:286\u2013289. doi: 10.1016/j.jep.2005.10.009.", "ArticleIdList": ["10.1016/j.jep.2005.10.009", "16343831"]}, {"Citation": "Jeyasri R., Muthuramalingam P., Suba V., Ramesh M., Chen J.T. Bacopa monnieri and Their Bioactive Compounds Inferred Multi-Target Treatment Strategy for Neurological Diseases: A Cheminformatics and System Pharmacology Approach. Biomolecules. 2020;10:536. doi: 10.3390/biom10040536.", "ArticleIdList": ["10.3390/biom10040536", "PMC7225932", "32252235"]}, {"Citation": "Chaudhari K.S., Tiwari N.R., Tiwari R.R., Sharma R.S. Neurocognitive Effect of Nootropic Drug Brahmi (Bacopa monnieri) in Alzheimer\u2019s Disease. Ann. Neurosci. 2017;24:111\u2013122. doi: 10.1159/000475900.", "ArticleIdList": ["10.1159/000475900", "PMC5448442", "28588366"]}, {"Citation": "Dhanasekaran M., Tharakan B., Holcomb L.A., Hitt A.R., Young K.A., Manyam B.V. Neuroprotective mechanisms of ayurvedic antidementia botanical Bacopa monniera. Phytother. Res. 2007;21:965\u2013969. doi: 10.1002/ptr.2195.", "ArticleIdList": ["10.1002/ptr.2195", "17604373"]}, {"Citation": "Roodenrys S., Booth D., Bulzomi S., Phipps A., Micallef C., Smoker J. Chronic effects of Brahmi (Bacopa monnieri) on human memory. Neuropsychopharmacology. 2002;27:279\u2013281. doi: 10.1016/S0893-133X(01)00419-5.", "ArticleIdList": ["10.1016/S0893-133X(01)00419-5", "12093601"]}, {"Citation": "Kumar N., Abichandani L.G., Thawani V., Gharpure K.J., Naidu M.U., Venkat Ramana G. Efficacy of Standardized Extract of Bacopa monnieri (Bacognize\u00ae) on Cognitive Functions of Medical Students: A Six-Week, Randomized Placebo-Controlled Trial. Evid.-Based Complement. Altern. Med. 2016;2016:4103423. doi: 10.1155/2016/4103423.", "ArticleIdList": ["10.1155/2016/4103423", "PMC5075615", "27803728"]}, {"Citation": "Saini N., Singh D., Sandhir R. Neuroprotective effects of Bacopa monnieri in experimental model of dementia. Neurochem. Res. 2012;37:1928\u20131937. doi: 10.1007/s11064-012-0811-4.", "ArticleIdList": ["10.1007/s11064-012-0811-4", "22700087"]}, {"Citation": "Dimpel W., Schombert L., Biller A. Psychophysiological Effects of Sideritis and Bacopa Extract and Three Combinations Thereof\u2014A Quantitative EEG Study in Subjects Suffering from Mild Cognitive Impairment (MCI) Adv. Alzheimer\u2019s Dis. 2016;5:64876. doi: 10.4236/aad.2016.51001.", "ArticleIdList": ["10.4236/aad.2016.51001"]}, {"Citation": "Heiner F., Feistel B., Wink M. Sideritis scardica extracts inhibit aggregation and toxicity of amyloid-\u03b2 in Caenorhabditis elegans used as a model for Alzheimer\u2019s disease. PeerJ. 2018;6:e4683. doi: 10.7717/peerj.4683.", "ArticleIdList": ["10.7717/peerj.4683", "PMC5933321", "29736334"]}, {"Citation": "Zanotta D., Puricelli S., Bonoldi G. Cognitive effects of a dietary supplement made from extract of Bacopa monnieri, astaxanthin, phosphatidylserine, and vitamin E in subjects with mild cognitive impairment: A noncomparative, exploratory clinical study. Neuropsychiatr. Dis. Treat. 2014;10:225\u2013230. doi: 10.2147/NDT.S51092.", "ArticleIdList": ["10.2147/NDT.S51092", "PMC3921088", "24523587"]}, {"Citation": "Sunderland T., Hill J.L., Mellow A.M., Lawlor B.A., Gundersheimer J., Newhouse P.A., Grafman J.H. Clock drawing in Alzheimer\u2019s disease. A novel measure of dementia severity. J. Am. Geriatr. Soc. 1989;37:725\u2013729. doi: 10.1111/j.1532-5415.1989.tb02233.x.", "ArticleIdList": ["10.1111/j.1532-5415.1989.tb02233.x", "2754157"]}, {"Citation": "Francis P.T. The interplay of neurotransmitters in Alzheimer\u2019s disease. CNS Spectr. 2005;10:6\u20139. doi: 10.1017/S1092852900014164.", "ArticleIdList": ["10.1017/S1092852900014164", "16273023"]}, {"Citation": "Prabhakar S., Vishnu V.Y., Modi M., Mohanty M., Sharma A., Medhi B., Mittal B.R., Khandelwal N., Goyal M.K., Lal V., et al. Efficacy of Bacopa Monnieri (Brahmi) and Donepezil in Alzheimer\u2019s Disease and Mild Cognitive Impairment: A Randomized Double-Blind Parallel Phase 2b Study. Ann. Indian Acad. Neurol. 2020;23:767\u2013773. doi: 10.4103/aian.AIAN_610_19.", "ArticleIdList": ["10.4103/aian.AIAN_610_19", "PMC7900738", "33688125"]}, {"Citation": "McKenna D.J., Jones K., Hughes K. Efficacy, safety, and use of ginkgo biloba in clinical and preclinical applications. Altern. Ther. Health Med. 2001;7:70\u201386, 88\u201390.", "ArticleIdList": ["11565403"]}, {"Citation": "Silberstein R.B., Pipingas A., Song J., Camfield D.A., Nathan P.J., Stough C. Examining brain-cognition effects of ginkgo biloba extract: Brain activation in the left temporal and left prefrontal cortex in an object working memory task. Evid.-Based Complement. Altern. Med. 2011;2011:164139. doi: 10.1155/2011/164139.", "ArticleIdList": ["10.1155/2011/164139", "PMC3166615", "21941584"]}, {"Citation": "Singh S.K., Srivastav S., Castellani R.J., Plascencia-Villa G., Perry G. Neuroprotective and Antioxidant Effect of Ginkgo biloba Extract Against AD and Other Neurological Disorders. Neurotherapeutics. 2019;16:666\u2013674. doi: 10.1007/s13311-019-00767-8.", "ArticleIdList": ["10.1007/s13311-019-00767-8", "PMC6694352", "31376068"]}, {"Citation": "Diamond B.J., Shiflett S.C., Feiwel N., Matheis R.J., Noskin O., Richards J.A., Schoenberger N.E. Ginkgo biloba extract: Mechanisms and clinical indications. Arch. Phys. Med. Rehabil. 2000;81:668\u2013678. doi: 10.1016/S0003-9993(00)90052-2.", "ArticleIdList": ["10.1016/S0003-9993(00)90052-2", "10807109"]}, {"Citation": "Li Z.Y., Chung Y.H., Shin E.J., Dang D.K., Jeong J.H., Ko S.K., Nah S.Y., Baik T.G., Jhoo J.H., Ong W.Y., et al. YY-1224, a terpene trilactone-strengthened Ginkgo biloba, attenuates neurodegenerative changes induced by \u03b2-amyloid (1-42) or double transgenic overexpression of APP and PS1 via inhibition of cyclooxygenase-2. J. Neuroinflamm. 2017;14:94. doi: 10.1186/s12974-017-0866-x.", "ArticleIdList": ["10.1186/s12974-017-0866-x", "PMC5408406", "28449688"]}, {"Citation": "Yang G., Wang Y., Sun J., Zhang K., Liu J. Ginkgo Biloba for Mild Cognitive Impairment and Alzheimer\u2019s Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Curr. Top. Med. Chem. 2016;16:520\u2013528. doi: 10.2174/1568026615666150813143520.", "ArticleIdList": ["10.2174/1568026615666150813143520", "26268332"]}, {"Citation": "Mahmoudian-Sani M.R., Hashemzadeh-Chaleshtori M., Asadi-Samani M., Yang Q. Ginkgo biloba in the treatment of tinnitus: An updated literature review. Int. Tinnitus J. 2017;21:58\u201362. doi: 10.5935/0946-5448.20170011.", "ArticleIdList": ["10.5935/0946-5448.20170011", "28723603"]}, {"Citation": "Park Y.J., Kim M.J., Kim H.R., Yi M.S., Chung K.H., Oh S.M. Chemopreventive effects of Ginkgo biloba extract in estrogen-negative human breast cancer cells. Arch. Pharm. Res. 2013;36:102\u2013108. doi: 10.1007/s12272-013-0002-0.", "ArticleIdList": ["10.1007/s12272-013-0002-0", "23335025"]}, {"Citation": "Bastianetto S., Ramassamy C., Dor\u00e9 S., Christen Y., Poirier J., Quirion R. The Ginkgo biloba extract (EGb 761) protects hippocampal neurons against cell death induced by beta-amyloid. Eur. J. Neurosci. 2000;12:1882\u20131890. doi: 10.1046/j.1460-9568.2000.00069.x.", "ArticleIdList": ["10.1046/j.1460-9568.2000.00069.x", "10886329"]}, {"Citation": "Ryu K.H., Han H.Y., Lee S.Y., Jeon S.D., Im G.J., Lee B.Y., Kim K., Lim K.M., Chung J.H. Ginkgo biloba extract enhances antiplatelet and antithrombotic effects of cilostazol without prolongation of bleeding time. Thromb. Res. 2009;124:328\u2013334. doi: 10.1016/j.thromres.2009.02.010.", "ArticleIdList": ["10.1016/j.thromres.2009.02.010", "19349067"]}, {"Citation": "Amri H., Ogwuegbu S.O., Boujrad N., Drieu K., Papadopoulos V. In vivo regulation of peripheral-type benzodiazepine receptor and glucocorticoid synthesis by Ginkgo biloba extract EGb 761 and isolated ginkgolides. Endocrinology. 1996;137:5707\u20135718. doi: 10.1210/endo.137.12.8940403.", "ArticleIdList": ["10.1210/endo.137.12.8940403", "8940403"]}, {"Citation": "Smith J.V., Burdick A.J., Golik P., Khan I., Wallace D., Luo Y. Anti-apoptotic properties of Ginkgo biloba extract EGb 761 in differentiated PC12 cells. Cell. Mol. Biol. 2002;48:699\u2013707.", "ArticleIdList": ["12396082"]}, {"Citation": "Bastianetto S., Zheng W.H., Quirion R. The Ginkgo biloba extract (EGb 761) protects and rescues hippocampal cells against nitric oxide-induced toxicity: Involvement of its flavonoid constituents and protein kinase C. J. Neurochem. 2000;74:2268\u20132277. doi: 10.1046/j.1471-4159.2000.0742268.x.", "ArticleIdList": ["10.1046/j.1471-4159.2000.0742268.x", "10820186"]}, {"Citation": "Gong Q.H., Wu Q., Huang X.N., Sun A.S., Shi J.S. Protective effects of Ginkgo biloba leaf extract on aluminum-induced brain dysfunction in rats. Life Sci. 2005;77:140\u2013148. doi: 10.1016/j.lfs.2004.10.067.", "ArticleIdList": ["10.1016/j.lfs.2004.10.067", "15862599"]}, {"Citation": "Le Bars P.L., Katz M.M., Berman N., Itil T.M., Freedman A.M., Schatzberg A.F. A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group. JAMA. 1997;278:1327\u20131332. doi: 10.1001/jama.1997.03550160047037.", "ArticleIdList": ["10.1001/jama.1997.03550160047037", "9343463"]}, {"Citation": "Janssen I.M., Sturtz S., Skipka G., Zentner A., Velasco Garrido M., Busse R. Ginkgo biloba in Alzheimer\u2019s disease: A systematic review. Wien. Med. Wochenschr. 2010;160:539\u2013546. doi: 10.1007/s10354-010-0844-8.", "ArticleIdList": ["10.1007/s10354-010-0844-8", "21170694"]}, {"Citation": "Hashiguchi M., Ohta Y., Shimizu M., Maruyama J., Mochizuki M. Meta-analysis of the efficacy and safety of Ginkgo biloba extract for the treatment of dementia. J. Pharm. Health Care Sci. 2015;1:14. doi: 10.1186/s40780-015-0014-7.", "ArticleIdList": ["10.1186/s40780-015-0014-7", "PMC4729005", "26819725"]}, {"Citation": "Orhan I.E. Centella asiatica (L.) Urban: From Traditional Medicine to Modern Medicine with Neuroprotective Potential. Evid.-Based Complement. Altern. Med. 2012;2012:946259. doi: 10.1155/2012/946259.", "ArticleIdList": ["10.1155/2012/946259", "PMC3359802", "22666298"]}, {"Citation": "Gohil K.J., Patel J.A., Gajjar A.K. Pharmacological Review on Centella asiatica: A Potential Herbal Cure-all. Indian J. Pharm. Sci. 2010;72:546\u2013556. doi: 10.4103/0250-474X.78519.", "ArticleIdList": ["10.4103/0250-474X.78519", "PMC3116297", "21694984"]}, {"Citation": "Lokanathan Y., Omar N., Ahmad Puzi N.N., Saim A., Hj Idrus R. Recent Updates in Neuroprotective and Neuroregenerative Potential of Centella asiatica. Malays. J. Med. Sci. 2016;23:4\u201314.", "ArticleIdList": ["PMC4975583", "27540320"]}, {"Citation": "Xu Y., Cao Z., Khan I., Luo Y. Gotu Kola (Centella Asiatica) extract enhances phosphorylation of cyclic AMP response element binding protein in neuroblastoma cells expressing amyloid beta peptide. J. Alzheimer\u2019s Dis. 2008;13:341\u2013349. doi: 10.3233/JAD-2008-13311.", "ArticleIdList": ["10.3233/JAD-2008-13311", "18431001"]}, {"Citation": "da Rocha M.D., Viegas F.P., Campos H.C., Nicastro P.C., Fossaluzza P.C., Fraga C.A., Barreiro E.J., Viegas C., Jr. The role of natural products in the discovery of new drug candidates for the treatment of neurodegenerative disorders II: Alzheimer\u2019s disease. CNS Neurol. Disord. Drug Targets. 2011;10:251\u2013270. doi: 10.2174/187152711794480429.", "ArticleIdList": ["10.2174/187152711794480429", "20874701"]}, {"Citation": "Mohandas Rao K.G., Muddanna Rao S., Gurumadhva Rao S. Centella asiatica (L.) leaf extract treatment during the growth spurt period enhances hippocampal CA3 neuronal dendritic arborization in rats. Evid.-Based Complement. Altern. Med. 2006;3:349\u2013357. doi: 10.1093/ecam/nel024.", "ArticleIdList": ["10.1093/ecam/nel024", "PMC1513148", "16951719"]}, {"Citation": "Kim S.R., Koo K.A., Lee M.K., Park H.G., Jew S.S., Cha K.H., Kim Y.C. Asiatic acid derivatives enhance cognitive performance partly by improving acetylcholine synthesis. J. Pharm. Pharmacol. 2004;56:1275\u20131282. doi: 10.1211/0022357044391.", "ArticleIdList": ["10.1211/0022357044391", "15482642"]}, {"Citation": "Wattanathorn J., Mator L., Muchimapura S., Tongun T., Pasuriwong O., Piyawatkul N., Yimtae K., Sripanidkulchai B., Singkhoraard J. Positive modulation of cognition and mood in the healthy elderly volunteer following the administration of Centella asiatica. J. Ethnopharmacol. 2008;116:325\u2013332. doi: 10.1016/j.jep.2007.11.038.", "ArticleIdList": ["10.1016/j.jep.2007.11.038", "18191355"]}, {"Citation": "Abu-Izneid T., Rauf A., Khalil A.A., Olatunde A., Khalid A., Alhumaydhi F.A., Aljohani A.S.M., Sahab Uddin M., Heydari M., Khayrullin M., et al. Nutritional and health beneficial properties of saffron (Crocus sativus L): A comprehensive review. Crit. Rev. Food Sci. Nutr. 2020:1\u201324. doi: 10.1080/10408398.2020.1857682.", "ArticleIdList": ["10.1080/10408398.2020.1857682", "33327732"]}, {"Citation": "Serrano-D\u00edaz J., S\u00e1nchez A.M., Maggi L., Mart\u00ednez-Tom\u00e9 M., Garc\u00eda-Diz L., Murcia M.A., Alonso G.L. Increasing the applications of Crocus sativus flowers as natural antioxidants. J. Food Sci. 2012;77:C1162\u2013C1168. doi: 10.1111/j.1750-3841.2012.02926.x.", "ArticleIdList": ["10.1111/j.1750-3841.2012.02926.x", "23057806"]}, {"Citation": "Srivastava R., Ahmed H., Dixit R.K., Saraf S.A. Crocus sativus L.: A comprehensive review. Pharmacogn. Rev. 2010;4:200\u2013208. doi: 10.4103/0973-7847.70919.", "ArticleIdList": ["10.4103/0973-7847.70919", "PMC3249922", "22228962"]}, {"Citation": "Bathaie S.Z., Mousavi S.Z. New applications and mechanisms of action of saffron and its important ingredients. Crit. Rev. Food Sci. Nutr. 2010;50:761\u2013786. doi: 10.1080/10408390902773003.", "ArticleIdList": ["10.1080/10408390902773003", "20830635"]}, {"Citation": "Akhondzadeh S., Sabet M.S., Harirchian M.H., Togha M., Cheraghmakani H., Razeghi S., Hejazi S., Yousefi M.H., Alimardani R., Jamshidi A., et al. Saffron in the treatment of patients with mild to moderate Alzheimer\u2019s disease: A 16-week, randomized and placebo-controlled trial. J. Clin. Pharm. Ther. 2010;35:581\u2013588. doi: 10.1111/j.1365-2710.2009.01133.x.", "ArticleIdList": ["10.1111/j.1365-2710.2009.01133.x", "20831681"]}, {"Citation": "Farokhnia M., Shafiee Sabet M., Iranpour N., Gougol A., Yekehtaz H., Alimardani R., Farsad F., Kamalipour M., Akhondzadeh S. Comparing the efficacy and safety of Crocus sativus L. with memantine in patients with moderate to severe Alzheimer\u2019s disease: A double-blind randomized clinical trial. Hum. Psychopharmacol. 2014;29:351\u2013359. doi: 10.1002/hup.2412.", "ArticleIdList": ["10.1002/hup.2412", "25163440"]}, {"Citation": "Kim D.S., Park S.Y., Kim J.K. Curcuminoids from Curcuma longa L. (Zingiberaceae) that protect PC12 rat pheochromocytoma and normal human umbilical vein endothelial cells from betaA(1-42) insult. Neurosci. Lett. 2001;303:57\u201361. doi: 10.1016/S0304-3940(01)01677-9.", "ArticleIdList": ["10.1016/S0304-3940(01)01677-9", "11297823"]}, {"Citation": "Jurenka J.S. Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: A review of preclinical and clinical research. Altern. Med. Rev. 2009;14:141\u2013153.", "ArticleIdList": ["19594223"]}, {"Citation": "Ammon H.P., Wahl M.A. Pharmacology of Curcuma longa. Planta Med. 1991;57:1\u20137. doi: 10.1055/s-2006-960004.", "ArticleIdList": ["10.1055/s-2006-960004", "2062949"]}, {"Citation": "Hewlings S.J., Kalman D.S. Curcumin: A Review of Its Effects on Human Health. Foods. 2017;6:92. doi: 10.3390/foods6100092.", "ArticleIdList": ["10.3390/foods6100092", "PMC5664031", "29065496"]}, {"Citation": "Prasad S., Tyagi A.K., Aggarwal B.B. Recent developments in delivery, bioavailability, absorption and metabolism of curcumin: The golden pigment from golden spice. Cancer Res. Treat. 2014;46:2\u201318. doi: 10.4143/crt.2014.46.1.2.", "ArticleIdList": ["10.4143/crt.2014.46.1.2", "PMC3918523", "24520218"]}, {"Citation": "Sharifi-Rad J., Rayess Y.E., Rizk A.A., Sadaka C., Zgheib R., Zam W., Sestito S., Rapposelli S., Neffe-Skoci\u0144ska K., Zieli\u0144ska D., et al. Turmeric and Its Major Compound Curcumin on Health: Bioactive Effects and Safety Profiles for Food, Pharmaceutical, Biotechnological and Medicinal Applications. Front. Pharmacol. 2020;11:01021. doi: 10.3389/fphar.2020.01021.", "ArticleIdList": ["10.3389/fphar.2020.01021", "PMC7522354", "33041781"]}, {"Citation": "Mishra S., Palanivelu K. The effect of curcumin (turmeric) on Alzheimer\u2019s disease: An overview. Ann. Indian Acad. Neurol. 2008;11:13\u201319. doi: 10.4103/0972-2327.40220.", "ArticleIdList": ["10.4103/0972-2327.40220", "PMC2781139", "19966973"]}, {"Citation": "Epstein J., Sanderson I.R., Macdonald T.T. Curcumin as a therapeutic agent: The evidence from in vitro, animal and human studies. Br. J. Nutr. 2010;103:1545\u20131557. doi: 10.1017/S0007114509993667.", "ArticleIdList": ["10.1017/S0007114509993667", "20100380"]}, {"Citation": "Maheshwari R.K., Singh A.K., Gaddipati J., Srimal R.C. Multiple biological activities of curcumin: A short review. Life Sci. 2006;78:2081\u20132087. doi: 10.1016/j.lfs.2005.12.007.", "ArticleIdList": ["10.1016/j.lfs.2005.12.007", "16413584"]}, {"Citation": "Yang F., Lim G.P., Begum A.N., Ubeda O.J., Simmons M.R., Ambegaokar S.S., Chen P.P., Kayed R., Glabe C.G., Frautschy S.A., et al. Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J. Biol. Chem. 2005;280:5892\u20135901. doi: 10.1074/jbc.M404751200.", "ArticleIdList": ["10.1074/jbc.M404751200", "15590663"]}, {"Citation": "Lim G.P., Chu T., Yang F., Beech W., Frautschy S.A., Cole G.M. The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J. Neurosci. 2001;21:8370\u20138377. doi: 10.1523/JNEUROSCI.21-21-08370.2001.", "ArticleIdList": ["10.1523/JNEUROSCI.21-21-08370.2001", "PMC6762797", "11606625"]}, {"Citation": "Zhu L.N., Mei X., Zhang Z.G., Xie Y.P., Lang F. Curcumin intervention for cognitive function in different types of people: A systematic review and meta-analysis. Phytother. Res. 2019;33:524\u2013533. doi: 10.1002/ptr.6257.", "ArticleIdList": ["10.1002/ptr.6257", "30575152"]}, {"Citation": "Kou J., Wang M., Shi J., Zhang H., Pu X., Song S., Yang C., Yan Y., D\u00f6ring Y., Xie X., et al. Curcumin Reduces Cognitive Deficits by Inhibiting Neuroinflammation through the Endoplasmic Reticulum Stress Pathway in Apolipoprotein E4 Transgenic Mice. ACS Omega. 2021;6:6654\u20136662. doi: 10.1021/acsomega.0c04810.", "ArticleIdList": ["10.1021/acsomega.0c04810", "PMC7970496", "33748578"]}, {"Citation": "Wang C., Zhang X., Teng Z., Zhang T., Li Y. Downregulation of PI3K/Akt/mTOR signaling pathway in curcumin-induced autophagy in APP/PS1 double transgenic mice. Eur. J. Pharmacol. 2014;740:312\u2013320. doi: 10.1016/j.ejphar.2014.06.051.", "ArticleIdList": ["10.1016/j.ejphar.2014.06.051", "25041840"]}, {"Citation": "Anand P., Kunnumakkara A.B., Newman R.A., Aggarwal B.B. Bioavailability of curcumin: Problems and promises. Mol. Pharm. 2007;4:807\u2013818. doi: 10.1021/mp700113r.", "ArticleIdList": ["10.1021/mp700113r", "17999464"]}, {"Citation": "Vyas A., Dandawate P., Padhye S., Ahmad A., Sarkar F. Perspectives on new synthetic curcumin analogs and their potential anticancer properties. Curr. Pharm. Des. 2013;19:2047\u20132069.", "ArticleIdList": ["PMC3788358", "23116312"]}, {"Citation": "Chainoglou E., Hadjipavlou-Litina D. Curcumin analogues and derivatives with anti-proliferative and anti-inflammatory activity: Structural characteristics and molecular targets. Expert Opin. Drug Discov. 2019;14:821\u2013842. doi: 10.1080/17460441.2019.1614560.", "ArticleIdList": ["10.1080/17460441.2019.1614560", "31094233"]}, {"Citation": "Katsori A.M., Chatzopoulou M., Dimas K., Kontogiorgis C., Patsilinakos A., Trangas T., Hadjipavlou-Litina D. Curcumin analogues as possible anti-proliferative & anti-inflammatory agents. Eur. J. Med. Chem. 2011;46:2722\u20132735. doi: 10.1016/j.ejmech.2011.03.060.", "ArticleIdList": ["10.1016/j.ejmech.2011.03.060", "21514701"]}, {"Citation": "Wan Y., Liang Y., Liang F., Shen N., Shinozuka K., Yu J.T., Ran C., Quan Q., Tanzi R.E., Zhang C. A Curcumin Analog Reduces Levels of the Alzheimer\u2019s Disease-Associated Amyloid-\u03b2 Protein by Modulating A\u03b2PP Processing and Autophagy. J. Alzheimer\u2019s Dis. 2019;72:761\u2013771. doi: 10.3233/JAD-190562.", "ArticleIdList": ["10.3233/JAD-190562", "31640096"]}, {"Citation": "Voulgaropoulou S.D., van Amelsvoort T., Prickaerts J., Vingerhoets C. The effect of curcumin on cognition in Alzheimer\u2019s disease and healthy aging: A systematic review of pre-clinical and clinical studies. Brain Res. 2019;1725:146476. doi: 10.1016/j.brainres.2019.146476.", "ArticleIdList": ["10.1016/j.brainres.2019.146476", "31560864"]}, {"Citation": "Baum L., Ng A. Curcumin interaction with copper and iron suggests one possible mechanism of action in Alzheimer\u2019s disease animal models. J. Alzheimer\u2019s Dis. 2004;6:367\u2013377. doi: 10.3233/JAD-2004-6403.", "ArticleIdList": ["10.3233/JAD-2004-6403", "15345806"]}, {"Citation": "Wang P., Su C., Li R., Wang H., Ren Y., Sun H., Yang J., Sun J., Shi J., Tian J., et al. Mechanisms and effects of curcumin on spatial learning and memory improvement in APPswe/PS1dE9 mice. J. Neurosci. Res. 2014;92:218\u2013231. doi: 10.1002/jnr.23322.", "ArticleIdList": ["10.1002/jnr.23322", "24273069"]}, {"Citation": "Bassani T.B., Turnes J.M., Moura E.L.R., Bonato J.M., C\u00f3ppola-Segovia V., Zanata S.M., Oliveira R., Vital M. Effects of curcumin on short-term spatial and recognition memory, adult neurogenesis and neuroinflammation in a streptozotocin-induced rat model of dementia of Alzheimer\u2019s type. Behav. Brain Res. 2017;335:41\u201354. doi: 10.1016/j.bbr.2017.08.014.", "ArticleIdList": ["10.1016/j.bbr.2017.08.014", "28801114"]}, {"Citation": "Zatta P., Drago D., Bolognin S., Sensi S.L. Alzheimer\u2019s disease, metal ions and metal homeostatic therapy. Trends Pharmacol. Sci. 2009;30:346\u2013355. doi: 10.1016/j.tips.2009.05.002.", "ArticleIdList": ["10.1016/j.tips.2009.05.002", "19540003"]}, {"Citation": "Crist\u00f3v\u00e3o J.S., Santos R., Gomes C.M. Metals and Neuronal Metal Binding Proteins Implicated in Alzheimer\u2019s Disease. Oxid. Med. Cell Longev. 2016;2016:9812178. doi: 10.1155/2016/9812178.", "ArticleIdList": ["10.1155/2016/9812178", "PMC4736980", "26881049"]}, {"Citation": "Yan F.S., Sun J.L., Xie W.H., Shen L., Ji H.F. Neuroprotective Effects and Mechanisms of Curcumin-Cu(II) and -Zn(II) Complexes Systems and Their Pharmacological Implications. Nutrients. 2017;10:28. doi: 10.3390/nu10010028.", "ArticleIdList": ["10.3390/nu10010028", "PMC5793256", "29283372"]}, {"Citation": "Parachikova A., Green K.N., Hendrix C., LaFerla F.M. Formulation of a medical food cocktail for Alzheimer\u2019s disease: Beneficial effects on cognition and neuropathology in a mouse model of the disease. PLoS ONE. 2010;5:e14015. doi: 10.1371/journal.pone.0014015.", "ArticleIdList": ["10.1371/journal.pone.0014015", "PMC2984445", "21103342"]}, {"Citation": "Guo P., Wang D., Wang X., Feng H., Tang Y., Sun R., Zheng Y., Dong L., Zhao J., Zhang X., et al. Effect and mechanism of fuzhisan and donepezil on the sirtuin 1 pathway and amyloid precursor protein metabolism in PC12 cells. Mol. Med. Rep. 2016;13:3539\u20133546. doi: 10.3892/mmr.2016.4957.", "ArticleIdList": ["10.3892/mmr.2016.4957", "26936536"]}, {"Citation": "Patel N.V., Gordon M.N., Connor K.E., Good R.A., Engelman R.W., Mason J., Morgan D.G., Morgan T.E., Finch C.E. Caloric restriction attenuates Abeta-deposition in Alzheimer transgenic models. Neurobiol. Aging. 2005;26:995\u20131000. doi: 10.1016/j.neurobiolaging.2004.09.014.", "ArticleIdList": ["10.1016/j.neurobiolaging.2004.09.014", "15748777"]}, {"Citation": "Sydow A., Van der Jeugd A., Zheng F., Ahmed T., Balschun D., Petrova O., Drexler D., Zhou L., Rune G., Mandelkow E., et al. Tau-induced defects in synaptic plasticity, learning, and memory are reversible in transgenic mice after switching off the toxic Tau mutant. J. Neurosci. 2011;31:2511\u20132525. doi: 10.1523/JNEUROSCI.5245-10.2011.", "ArticleIdList": ["10.1523/JNEUROSCI.5245-10.2011", "PMC6623704", "21325519"]}, {"Citation": "Baum L., Lam C.W., Cheung S.K., Kwok T., Lui V., Tsoh J., Lam L., Leung V., Hui E., Ng C., et al. Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease. J. Clin. Psychopharmacol. 2008;28:110\u2013113. doi: 10.1097/jcp.0b013e318160862c.", "ArticleIdList": ["10.1097/jcp.0b013e318160862c", "18204357"]}, {"Citation": "Perry E.K., Pickering A.T., Wang W.W., Houghton P.J., Perry N.S. Medicinal plants and Alzheimer\u2019s disease: From ethnobotany to phytotherapy. J. Pharm. Pharmacol. 1999;51:527\u2013534. doi: 10.1211/0022357991772808.", "ArticleIdList": ["10.1211/0022357991772808", "10411211"]}, {"Citation": "Adams M., Gm\u00fcnder F., Hamburger M. Plants traditionally used in age related brain disorders\u2014A survey of ethnobotanical literature. J. Ethnopharmacol. 2007;113:363\u2013381. doi: 10.1016/j.jep.2007.07.016.", "ArticleIdList": ["10.1016/j.jep.2007.07.016", "17720341"]}, {"Citation": "Howes M.J., Houghton P.J. Ethnobotanical treatment strategies against Alzheimer\u2019s disease. Curr. Alzheimer Res. 2012;9:67\u201385. doi: 10.2174/156720512799015046.", "ArticleIdList": ["10.2174/156720512799015046", "22329652"]}, {"Citation": "Nabavi S.F., Braidy N., Orhan I.E., Badiee A., Daglia M., Nabavi S.M. Rhodiola rosea L. and Alzheimer\u2019s Disease: From Farm to Pharmacy. Phytother. Res. 2016;30:532\u2013539. doi: 10.1002/ptr.5569.", "ArticleIdList": ["10.1002/ptr.5569", "27059687"]}, {"Citation": "Sutalangka C., Wattanathorn J., Muchimapura S., Thukham-mee W. Moringa oleifera mitigates memory impairment and neurodegeneration in animal model of age-related dementia. Oxid. Med. Cell. Longev. 2013;2013:695936. doi: 10.1155/2013/695936.", "ArticleIdList": ["10.1155/2013/695936", "PMC3884855", "24454988"]}, {"Citation": "Farooqui A.A., Farooqui T., Madan A., Ong J.H., Ong W.Y. Ayurvedic Medicine for the Treatment of Dementia: Mechanistic Aspects. Evid.-Based Complement. Altern. Med. 2018;2018:2481076. doi: 10.1155/2018/2481076.", "ArticleIdList": ["10.1155/2018/2481076", "PMC5976976", "29861767"]}, {"Citation": "Chauhan N.B. Anti-amyloidogenic effect of Allium sativum in Alzheimer\u2019s transgenic model Tg2576. J. Herb. Pharmacother. 2003;3:95\u2013107. doi: 10.1080/J157v03n01_05.", "ArticleIdList": ["10.1080/J157v03n01_05", "15277073"]}, {"Citation": "Ray B., Chauhan N.B., Lahiri D.K. The \u201caged garlic extract\u201d (AGE) and one of its active ingredients S-allyl-L-cysteine (SAC) as potential preventive and therapeutic agents for Alzheimer\u2019s disease (AD) Curr. Med. Chem. 2011;18:3306\u20133313. doi: 10.2174/092986711796504664.", "ArticleIdList": ["10.2174/092986711796504664", "PMC3941700", "21728972"]}, {"Citation": "Choi S.J., Lee J.H., Heo H.J., Cho H.Y., Kim H.K., Kim C.J., Kim M.O., Suh S.H., Shin D.H. Punica granatum protects against oxidative stress in PC12 cells and oxidative stress-induced Alzheimer\u2019s symptoms in mice. J. Med. Food. 2011;14:695\u2013701. doi: 10.1089/jmf.2010.1452.", "ArticleIdList": ["10.1089/jmf.2010.1452", "21631359"]}, {"Citation": "Ahmed A.H., Subaiea G.M., Eid A., Li L., Seeram N.P., Zawia N.H. Pomegranate extract modulates processing of amyloid-\u03b2 precursor protein in an aged Alzheimer\u2019s disease animal model. Curr. Alzheimer Res. 2014;11:834\u2013843. doi: 10.2174/1567205011666141001115348.", "ArticleIdList": ["10.2174/1567205011666141001115348", "25274111"]}, {"Citation": "Cao C., Li Y., Liu H., Bai G., Mayl J., Lin X., Sutherland K., Nabar N., Cai J. The potential therapeutic effects of THC on Alzheimer\u2019s disease. J. Alzheimer\u2019s Dis. 2014;42:973\u2013984. doi: 10.3233/JAD-140093.", "ArticleIdList": ["10.3233/JAD-140093", "25024327"]}, {"Citation": "Scuderi C., Steardo L., Esposito G. Cannabidiol promotes amyloid precursor protein ubiquitination and reduction of beta amyloid expression in SHSY5YAPP+ cells through PPAR\u03b3 involvement. Phytother. Res. 2014;28:1007\u20131013. doi: 10.1002/ptr.5095.", "ArticleIdList": ["10.1002/ptr.5095", "24288245"]}, {"Citation": "Aso E., S\u00e1nchez-Pla A., Vegas-Lozano E., Maldonado R., Ferrer I. Cannabis-based medicine reduces multiple pathological processes in A\u03b2PP/PS1 mice. J. Alzheimer\u2019s Dis. 2015;43:977\u2013991. doi: 10.3233/JAD-141014.", "ArticleIdList": ["10.3233/JAD-141014", "25125475"]}, {"Citation": "Esposito G., Scuderi C., Valenza M., Togna G.I., Latina V., De Filippis D., Cipriano M., Carrat\u00f9 M.R., Iuvone T., Steardo L. Cannabidiol reduces A\u03b2-induced neuroinflammation and promotes hippocampal neurogenesis through PPAR\u03b3 involvement. PLoS ONE. 2011;6:e28668. doi: 10.1371/journal.pone.0028668.", "ArticleIdList": ["10.1371/journal.pone.0028668", "PMC3230631", "22163051"]}, {"Citation": "Vall\u00e9e A., Lecarpentier Y., Guillevin R., Vall\u00e9e J.N. Effects of cannabidiol interactions with Wnt/\u03b2-catenin pathway and PPAR\u03b3 on oxidative stress and neuroinflammation in Alzheimer\u2019s disease. Acta Biochim. Biophys. Sin. 2017;49:853\u2013866. doi: 10.1093/abbs/gmx073.", "ArticleIdList": ["10.1093/abbs/gmx073", "28981597"]}, {"Citation": "Iuvone T., Esposito G., Esposito R., Santamaria R., Di Rosa M., Izzo A.A. Neuroprotective effect of cannabidiol, a non-psychoactive component from Cannabis sativa, on beta-amyloid-induced toxicity in PC12 cells. J. Neurochem. 2004;89:134\u2013141. doi: 10.1111/j.1471-4159.2003.02327.x.", "ArticleIdList": ["10.1111/j.1471-4159.2003.02327.x", "15030397"]}, {"Citation": "Esposito G., Scuderi C., Savani C., Steardo L., Jr., De Filippis D., Cottone P., Iuvone T., Cuomo V., Steardo L. Cannabidiol in vivo blunts beta-amyloid induced neuroinflammation by suppressing IL-1beta and iNOS expression. Br. J. Pharmacol. 2007;151:1272\u20131279. doi: 10.1038/sj.bjp.0707337.", "ArticleIdList": ["10.1038/sj.bjp.0707337", "PMC2189818", "17592514"]}, {"Citation": "Wong W. Economic burden of Alzheimer disease and managed care considerations. Am. J. Manag. Care. 2020;26:S177\u2013S183. doi: 10.37765/ajmc.2020.88482.", "ArticleIdList": ["10.37765/ajmc.2020.88482", "32840331"]}, {"Citation": "Rafii M.S., Aisen P.S. Alzheimer\u2019s Disease Clinical Trials: Moving Toward Successful Prevention. CNS Drugs. 2019;33:99\u2013106. doi: 10.1007/s40263-018-0598-1.", "ArticleIdList": ["10.1007/s40263-018-0598-1", "PMC6367028", "30560544"]}, {"Citation": "Folch J., Petrov D., Ettcheto M., Abad S., S\u00e1nchez-L\u00f3pez E., Garc\u00eda M.L., Olloquequi J., Beas-Zarate C., Auladell C., Camins A. Current Research Therapeutic Strategies for Alzheimer\u2019s Disease Treatment. Neural Plast. 2016;2016:8501693. doi: 10.1155/2016/8501693.", "ArticleIdList": ["10.1155/2016/8501693", "PMC4735913", "26881137"]}, {"Citation": "Ngandu T., Lehtisalo J., Solomon A., Lev\u00e4lahti E., Ahtiluoto S., Antikainen R., B\u00e4ckman L., H\u00e4nninen T., Jula A., Laatikainen T., et al. A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): A randomised controlled trial. Lancet. 2015;385:2255\u20132263. doi: 10.1016/S0140-6736(15)60461-5.", "ArticleIdList": ["10.1016/S0140-6736(15)60461-5", "25771249"]}, {"Citation": "Zenaro E., Piacentino G., Constantin G. The blood-brain barrier in Alzheimer\u2019s disease. Neurobiol. Dis. 2017;107:41\u201356. doi: 10.1016/j.nbd.2016.07.007.", "ArticleIdList": ["10.1016/j.nbd.2016.07.007", "PMC5600438", "27425887"]}, {"Citation": "T\u00fcrker S., Onur E., Ozer Y. Nasal route and drug delivery systems. Pharm. World Sci. 2004;26:137\u2013142. doi: 10.1023/B:PHAR.0000026823.82950.ff.", "ArticleIdList": ["10.1023/B:PHAR.0000026823.82950.ff", "15230360"]}, {"Citation": "Keller L.A., Merkel O., Popp A. Intranasal drug delivery: Opportunities and toxicologic challenges during drug development. Drug Deliv. Transl. Res. 2021;1:1\u201323. doi: 10.1007/s13346-020-00891-5.", "ArticleIdList": ["10.1007/s13346-020-00891-5", "PMC7829061", "33491126"]}, {"Citation": "Miyake M.M., Bleier B.S. The blood-brain barrier and nasal drug delivery to the central nervous system. Am. J. Rhinol. Allergy. 2015;29:124\u2013127. doi: 10.2500/ajra.2015.29.4149.", "ArticleIdList": ["10.2500/ajra.2015.29.4149", "25785753"]}, {"Citation": "Erd\u0151 F., Bors L.A., Farkas D., Bajza \u00c1., Gizurarson S. Evaluation of intranasal delivery route of drug administration for brain targeting. Brain Res. Bull. 2018;143:155\u2013170. doi: 10.1016/j.brainresbull.2018.10.009.", "ArticleIdList": ["10.1016/j.brainresbull.2018.10.009", "30449731"]}, {"Citation": "Wu H., Hu K., Jiang X. From nose to brain: Understanding transport capacity and transport rate of drugs. Expert Opin. Drug Deliv. 2008;5:1159\u20131168. doi: 10.1517/17425247.5.10.1159.", "ArticleIdList": ["10.1517/17425247.5.10.1159", "18817519"]}, {"Citation": "Akhondzadeh S., Abbasi S.H. Herbal medicine in the treatment of Alzheimer\u2019s disease. Am. J. Alzheimer\u2019s Dis. Other Demen. 2006;21:113\u2013118. doi: 10.1177/153331750602100211.", "ArticleIdList": ["10.1177/153331750602100211", "PMC10833269", "16634467"]}, {"Citation": "Iqbal K., Grundke-Iqbal I. Alzheimer\u2019s disease, a multifactorial disorder seeking multitherapies. Alzheimer\u2019s Dement. 2010;6:420\u2013424. doi: 10.1016/j.jalz.2010.04.006.", "ArticleIdList": ["10.1016/j.jalz.2010.04.006", "PMC2946155", "20813343"]}, {"Citation": "Chen X., Drew J., Berney W., Lei W. Neuroprotective Natural Products for Alzheimer\u2019s Disease. Cells. 2021;10:1309. doi: 10.3390/cells10061309.", "ArticleIdList": ["10.3390/cells10061309", "PMC8225186", "34070275"]}, {"Citation": "Renaud J., Martinoli M.G. Considerations for the Use of Polyphenols as Therapies in Neurodegenerative Diseases. Int. J. Mol. Sci. 2019;20:1883. doi: 10.3390/ijms20081883.", "ArticleIdList": ["10.3390/ijms20081883", "PMC6514961", "30995776"]}, {"Citation": "Kumar A., Ahuja A., Ali J., Baboota S. Curcumin-loaded lipid nanocarrier for improving bioavailability, stability and cytotoxicity against malignant glioma cells. Drug Deliv. 2016;23:214\u2013229. doi: 10.3109/10717544.2014.909906.", "ArticleIdList": ["10.3109/10717544.2014.909906", "24825490"]}, {"Citation": "Smith A., Giunta B., Bickford P.C., Fountain M., Tan J., Shytle R.D. Nanolipidic particles improve the bioavailability and alpha-secretase inducing ability of epigallocatechin-3-gallate (EGCG) for the treatment of Alzheimer\u2019s disease. Int. J. Pharm. 2010;389:207\u2013212. doi: 10.1016/j.ijpharm.2010.01.012.", "ArticleIdList": ["10.1016/j.ijpharm.2010.01.012", "PMC5831366", "20083179"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "2", "Day": "4"}, {"Year": "2022", "Month": "2", "Day": "23"}, {"Year": "2022", "Month": "2", "Day": "25"}, {"Year": "2022", "Month": "3", "Day": "22", "Hour": "5", "Minute": "35"}, {"Year": "2022", "Month": "3", "Day": "23", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "3", "Day": "23", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "2", "Day": "26"}], "PublicationStatus": "epublish", "ArticleIdList": ["35314596", "PMC8938774", "10.3390/geriatrics7020024", "geriatrics7020024"]}}], "PubmedBookArticle": []}